Characterization and Therapeutic Potential of a Novel Lytic Bacteriophage vB_Kp_H122 Targeting Multidrug‐Resistant Hypervirulent Klebsiella pneumoniae of K57 Capsular Type
Transboundary and Emerging Diseases · 2026-01 · 2026 (1)
DOI: 10.1155/tbed/8429457 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transboundary and Emerging Diseases, online erschienen am 13.08.2026. Verfasst von Cuilong Fan und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin…. Hauptthemen laut MEDLINE: Klebsiella pneumoniae, Bacteriophages, Klebsiella Infections, Phage Therapy. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project, Central Public-Interest Scientific Institution Basal Research Fund.
Abstract (Originalsprache)
Klebsiella pneumoniae is an important zoonotic opportunistic pathogen. Of particular concern is the emergence of multidrug‐resistant hypervirulent K. pneumoniae (MDR‐hvKP), which represents a serious public health threat. Bacteriophage (phage) therapy has emerged as a promising solution to combat antibiotic‐resistant K. pneumoniae infections. Here, we characterize a novel lytic phage, vB_Kp_H122, that specifically targets K57 capsular‐type MDR‐hvKP. vB_Kp_H122 exhibited the characteristic morphology of a siphovirus and demonstrated efficient infection kinetics, with an optimal multiplicity of infection (MOI) of 0.001 and a latent period of ~5 min. It also demonstrated considerable stability across a pH range of 4–11 and at temperatures from 4°C to 50°C, as well as potent activity against K. pneumoniae biofilms. The phage has a linear double‐stranded DNA genome of 46,077 bp with a G + C content of 47.61% and belongs to a novel species within the genus Roufvirus . Its genome contained no identifiable genes associated with lysogeny, virulence, or antibiotic resistance, supporting its therapeutic safety. In a mouse infection model, a single dose of vB_Kp_H122 at 2 × 10 6 PFU significantly reduced bacterial loads in organs, alleviated pathological damage, and provided complete protection against lethal challenge with K57 MDR‐hvKP. These findings suggest that vB_Kp_H122 may have potential as an antibacterial candidate against K57 MDR‐hvKP isolates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China, caas.cn.
- Institute of Microbiology and Epizootics, Centre for Infection Medicine, School of Veterinary Medicine, Freie Universität Berlin, Berlin 14163, Germany, fu-berlin.de.
- Veterinary Centre for Resistance Research (TZR), School of Veterinary Medicine, Freie Universität Berlin, Berlin 14163, Germany, fu-berlin.de.
ORCID-Profile: Fang Xie, Wanjiang Zhang
Förderung
- Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project
- Central Public-Interest Scientific Institution Basal Research Fund
Zitieren
APA
Fan, C., Xu, Q., Schwarz, S., Liu, Y., Du, S., Lu, X., Yuan, Y., Lin, L., Xie, S., Xie, F., & Zhang, W. (2026). Characterization and Therapeutic Potential of a Novel Lytic Bacteriophage vB_Kp_H122 Targeting Multidrug‐Resistant Hypervirulent Klebsiella pneumoniae of K57 Capsular Type. Transboundary and Emerging Diseases, 2026(1). https://doi.org/10.1155/tbed/8429457
Vancouver
Fan C, Xu Q, Schwarz S, Liu Y, Du S, Lu X, et al. Characterization and Therapeutic Potential of a Novel Lytic Bacteriophage vB_Kp_H122 Targeting Multidrug‐Resistant Hypervirulent Klebsiella pneumoniae of K57 Capsular Type. Transboundary and Emerging Diseases. 2026;2026(1). doi:10.1155/tbed/8429457
BibTeX
@article{Fan2026,
author = {Fan, Cuilong and Xu, Qiu and Schwarz, Stefan and Liu, Yaowei and Du, Susu and Lu, Xiaofeng and Yuan, Yuxuan and Lin, Longhua and Xie, Shuangyu and Xie, Fang and Zhang, Wanjiang},
title = {Characterization and Therapeutic Potential of a Novel Lytic Bacteriophage vB_Kp_H122 Targeting Multidrug‐Resistant Hypervirulent Klebsiella pneumoniae of K57 Capsular Type},
journal = {Transboundary and Emerging Diseases},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/tbed/8429457}
}
EUVIMED